SECONDARY GENETIC ABBERATIONS AND THEIR EFFECT ON PROGNOSIS IN CORE BINDING FACTOR - ACUTE MYELOID LEUKEMIA (CBF-AML)

被引：0
|
作者：
Markova, J. [1 ]
Trnkova, Z. [1 ]
Maaloufova, J. [1 ]
Stary, J. [2 ]
Cetkovsky, P. [1 ]
Schwarz, J. [1 ]
机构：
[1] Inst Hematol & Blood Transfus, CR-12820 Prague 2, Czech Republic
[2] Fac Hosp Motol, Dept Pediat Hematol & Oncol, Prague 5, Czech Republic
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0501
引用
收藏
页码：203 / 203
页数：1
相关论文
共 50 条
  • [31] Core binding factor acute myeloid leukemia
    Mouchel, Pierre Luc
    HEMATOLOGIE, 2015, 21 (01): : 91 - 94
  • [32] Core binding factor acute myeloid leukemia
    Paschka, Peter
    SEMINARS IN ONCOLOGY, 2008, 35 (04) : 410 - 417
  • [33] Minimal Residual Disease Monitored With Fluorescence In Situ Hybridization (FISH) In CD34+CD38- Population Predicts Clinical Outcome In Core Binding Factor Acute Myeloid Leukemia (CBF-AML)
    Hu, Xiaoxia
    Wang, Libing
    Gao, Lei
    Xu, Sheng
    Gong, Shenglan
    Liu, Min
    Qiu, Huiying
    Xu, Xiaoqian
    Ni, Xiong
    Chen, Li
    Lu, Shuqing
    Chen, Jie
    Song, Xianmin
    Zhang, Weiping
    Yang, Jianmin
    Wang, Jianmin
    BLOOD, 2013, 122 (21)
  • [34] The core concepts of core binding factor acute myeloid leukemia: Current considerations for prognosis and treatment
    Darwish, Christina
    Farina, Kyle
    Tremblay, Douglas
    BLOOD REVIEWS, 2023, 62
  • [35] Outcome prediction in adult core binding factor (CBF) acute myeloid leukemia (AML) with gene expression profiling: A Cancer and Leukemia Group B (CALGB) study
    Paschka, P.
    Radmacher, M. D.
    Marcucci, G.
    Ruppert, A. S.
    Vukosavljevic, T.
    Whitman, S. P.
    Mrozek, K.
    Liu, C.
    Larson, R. A.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Effect of front-line therapy with fludarabine, cytarabine, filgrastim, and gemtuzumab ozogamicin (FLAG-GO) on outcome in core-binding factor associated acute myelogenous leukemia (CBF-AML)
    Borthakur, G.
    Jabbour, E.
    Wang, X.
    Cortes, J. E.
    Kashani, F. Ravandi
    Kadia, T. M.
    Bass, J.
    Brandt, M.
    Kantarjian, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Granulocytic sarcoma of Core-binding Factor (CBF) acute myeloid leukemia mimicking pancreatic cancer
    Schaefer, Henning Sebastian
    Becker, Heiko
    Schmitt-Graeff, Annette
    Luebbert, Michael
    LEUKEMIA RESEARCH, 2008, 32 (09) : 1472 - 1475
  • [38] Prognosis of patients with core binding factor acute myeloid leukemia after first relapse
    Kurosawa, Saiko
    Miyawaki, Shuichi
    Yamaguchi, Takuhiro
    Kanamori, Heiwa
    Sakura, Toru
    Moriuchi, Yukiyoshi
    Sano, Fumiaki
    Kobayashi, Takeshi
    Yasumoto, Atsushi
    Hatanaka, Kazuo
    Yanada, Masamitsu
    Nawa, Yuichiro
    Takeuchi, Jin
    Nakamura, Yukinori
    Fujisawa, Shin
    Shibayama, Hirohiko
    Miura, Ikuo
    Fukuda, Takahiro
    HAEMATOLOGICA, 2013, 98 (10) : 1525 - 1531
  • [39] CCND1 and CCND2 Mutations Are Frequent in Adults with Core-Binding Factor Acute Myeloid Leukemia (CBF-AML) with t(8;21)(q22; q22)
    Eisfeld, Ann-Kathrin
    Kohlschmidt, Jessica
    Schwind, Sebastian
    Nicolet, Deedra
    Blachly, James S.
    Orwick, Shelley
    Shah, Chandni
    Bainazar, Maryam
    Kroll, Karl
    Walker, Christopher J.
    Carroll, Andrew J.
    Powell, Bayard L.
    Stone, Richard M.
    Kolitz, Jonathan E.
    Baer, Maria R.
    de la Chapelle, Albert
    Mrozek, Krzysztof
    Byrd, John C.
    Bloomfield, Clara D.
    BLOOD, 2016, 128 (22)
  • [40] Core-Binding Factor Acute Myeloid Leukemia
    Sangle, Nikhil A.
    Perkins, Sherrie L.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2011, 135 (11) : 1504 - 1509
12345